期刊文献+

乳腺癌术后植入物乳房重建两步法的应用探讨 被引量:4

Application of two-stage implant-based breast reconstruction after breast cancer surgery
原文传递
导出
摘要 目的:探讨乳腺癌术后两步法植入物乳房重建的手术疗效及临床应用价值。方法:回顾性分析2018年1月—2020年12月首都医科大学附属北京同仁医院乳腺中心完成保留乳头乳晕复合体或保留皮肤的皮下腺体全切除、一期置入皮肤扩张器,接受放疗后完成永久假体置换的乳腺癌患者共32例,记录患者的手术时间、置换手术与放疗的间隔时间、假体体积、扩张器内0.9%氯化钠溶液体积与假体体积差值、术后引流管保留时间、置换术后乳房外形满意度及并发症情况。结果:手术时间平均为(67.81±19.71) min;置换手术与放疗时间间隔平均为(9.88±2.00)个月;扩张器内0.9%氯化钠溶液体积平均为(225.47±56.83) mL,假体体积平均为(259.06±70.88) mL,假体体积与扩张器内0.9%氯化钠溶液体积差值平均为(33.59±14.88) mL;假体较扩张器增加的体积比例平均为(13.65±5.19)%;术后引流管保留时间平均为(9.03±1.40) d;置换术后乳房外形的满意度:优良23例(71.9%),一般8例(25.0%),差1例(3.1%);术后并发症:切口脂肪液化裂开1例(3.1%),血清肿2例(6.3%),未出现假体外露、取出等严重并发症。结论:对于乳房切除术后植入物乳房重建且需要放疗的乳腺癌患者,选择"针对扩张器放疗"的两步法,在放疗后6个月以上进行永久性假体置换手术的安全性好,同时通过松解包膜、重建乳房下皱襞以及必要的健侧乳房整形手术,可以达到更好的对称性和美学效果。 Objective:To investigate the efficacy and clinical value of two-stage implant-based breast reconstruction after total mastectomy for breast cancer patients.Methods:Thirty-two patients with breast cancer,who underwent nipple-sparing mastectomy or skin-sparing mastectomy,primary skin expander implantation,and permanent implant replacement after radiotherapy from January 2018 to December 2020 in the Breast Center,Beijing Tongren Hospital,Capital Medical University were analyzed retrospectively.Record the operation time of the patient,the interval between replacement surgery and radiotherapy,prosthesis volume,the difference between the volume of 0.9%sodium chloride solution in the dilator and the volume of the prosthesis,the retention time of the postoperative drainage tube,the satisfaction of the breast shape and the complications after the replacement.Results:The average operation time was(67.81±19.71)min;the average time interval between replacement surgery and radiotherapy was(9.88±2.00)months;the average volume of 0.9%sodium chloride solution in the dilator was(225.47±56.83)mL,and the average prosthesis volume was(259.06±70.88)mL,the average difference between the volume of the prosthesis and the volume of 0.9%sodium chloride solution in the dilator was(33.59±14.88)mL;the volume of the prosthesis is increased by an average of(13.65±5.19)%compared with the dilator;the average time of drainage tube retained after the operation was(9.03±1.40)d;satisfaction with breast shape after replacement:excellent in 23 cases(71.9%),general in 8 cases(25.0%),poor in 1 case(3.1%);postoperative complications:incision fat liquefaction 1 case of dehiscence(3.1%),2 cases of seroma(6.3%),no serious complications such as external exposure and removal of the prosthesis.Conclusions:For patients with breast cancer,who need breast reconstruction after mastectomy,the two-stage implant-based breast reconstruction in which the replacement operation will be carried out more than 6 months after radiotherapy is safe.Moreover,achieve better symmetry and aesthetic effect by releasing the capsule,reconstructing the inframammary fold,and necessary plastic surgery of the contralateral breast.
作者 张冰 关山 王宇 张开通 岳朝森 Zhang Bing;Guan Shan;Wang Yu;Zhang Kaitong;Yue Chaosen(Breast Center,Beijing Tongren Hospital,Capital Medical University,Beijing 100176,China)
出处 《国际外科学杂志》 2021年第9期618-621,F0004,共5页 International Journal of Surgery
关键词 乳腺肿瘤 外科手术 乳房重建 保留乳头乳晕复合体乳房切除术 Breast neoplasms Surgical procedures,operative Breast reconstruction Nipple-areola complex-sparing mastectomy
  • 相关文献

参考文献6

二级参考文献44

  • 1无,刘荫华,朱玮.乳腺癌术后乳房重建中国专家共识(2019版)[J].中国实用外科杂志,2019,39(11):1145-1147. 被引量:37
  • 2王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 4陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:34
  • 5全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤死亡报告-全国第三次死因回顾抽样调查[M].北京:人民卫生出版社,2010,6.
  • 6STEWART B W, KLEIHUES P. World Cancer Report[M]. Lyon: IARC Press, 2003: 188-193.
  • 7FERLAY J, SHIN H R, BRAY F, et al. GLOBOCAN 2008 vl. 2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [DB/OL]. Lyon: International Agency for Research on Cancer, 201 012012-02-01]. http: //globocan. iarc. fr.
  • 8全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.2010中国肿瘤登记年报(中国肿瘤登记地区2007年肿瘤发病死亡)[M].北京:军事医学科学出版社,2011:1-14.
  • 9全国肿瘤防治研究办公室 卫生部卫生统计信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997)[M].北京:中国医药科技出版社,2002..
  • 10赵平,陈万青,孔灵芝.中国癌症发病与死亡2003-2007[M].北京:军事医学科学出版社,2012:79-90.

共引文献1288

同被引文献50

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部